These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10282682)

  • 41. P & T Committee role in advocating rational therapeutics.
    Borreson R
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. P & T Committee formulary requests: criteria for admission.
    Weintraub M; Guttmacher L
    Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What process does your P&T Committee use to obtain staff physicians' input regarding formulary decisions?
    Tompkins GC
    Hosp Formul; 1992 Feb; 27(2):197. PubMed ID: 10116717
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug product selection by formulary committees in Sweden.
    Lilja J
    Am J Hosp Pharm; 1979 Aug; 36(8):1042, 1044. PubMed ID: 484560
    [No Abstract]   [Full Text] [Related]  

  • 45. Preparing the P & T committee agenda for new drug requests.
    Standish RC; Evans PJ; Bell JE
    Hosp Formul; 1984 Sep; 19(9):792, 795-800. PubMed ID: 10267929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cephalosporin-use restrictions in teaching hospitals.
    McCloskey WW; Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Achieving parenteral nutrition cost savings through prescribing guidelines and formulary restrictions.
    Maswoswe JJ; Newcomer DR; Quandt CM
    Am J Hosp Pharm; 1987 Jun; 44(6):1376-81. PubMed ID: 3113237
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Operation, formulary decision-making activities of a P & T Committee in a managed care setting.
    Adams J; Richardson J
    Hosp Formul; 1991 Apr; 26(4):291-4, 300-1. PubMed ID: 10109798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. P & T Committee interview: communication and education contribute to an effective formulary system.
    Hinthorn D; Godwin H
    Hosp Formul; 1989 May; 24(5):281-4, 286-7. PubMed ID: 10292977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC; Okpara IR; Agnese WB; Toscani M
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The P&T committee: Clinical Hospital Center, Zagreb, Yugoslavia.
    Vrhovac B; Francetic I
    Hosp Formul; 1984 Dec; 19(12):1158-9, 1162. PubMed ID: 10269439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
    Skaer TL
    Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulary decisions concerning cephalosporins.
    Fuentes RJ
    Am J Hosp Pharm; 1979 Mar; 36(3):296, 300. PubMed ID: 420220
    [No Abstract]   [Full Text] [Related]  

  • 57. Cost savings through formulary implementation and group purchasing in four therapeutic categories.
    Sylvester KL; Wudds TW
    Hosp Formul; 1986 Mar; 21(3):357-60, 369-70. PubMed ID: 10275579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Challenges of a P & T Committee in a community teaching hospital.
    Cooke DH; Kessler J
    Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The goals and functions of a P & T committee.
    Sudds TW; Williams RR
    Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion.
    Keeffe EB; Harper JM; LeMay A; Sherrin TP; Siepler JK
    Hosp Formul; 1991 Nov; 26 Suppl D():13-9. PubMed ID: 10136560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.